These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 638875)

  • 1. Opiate-like naloxone-reversible actions of somatostatin given intracerebrally.
    Rezek M; Havlicek V; Leybin L; LaBella FS; Friesen H
    Can J Physiol Pharmacol; 1978 Apr; 56(2):227-31. PubMed ID: 638875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of somatostatin and enkephalins on the guinea pig ileum and the rat vas deferens.
    Jhamandas K; Elliott J
    Can J Physiol Pharmacol; 1980 Nov; 58(11):1389-92. PubMed ID: 6111385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate-like naloxone-reversible effects of androsterone sulfate in rats.
    LaBella F; Havlicek V; Pinsky C; Leybin L
    Can J Physiol Pharmacol; 1978 Dec; 56(6):940-4. PubMed ID: 743633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate properties of SKF 525A.
    Ho TK; LaBella FS; Pinsky C
    Can J Physiol Pharmacol; 1978 Aug; 56(4):550-4. PubMed ID: 210915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of centrally administered somatostatin and two related peptides on intestinal absorption of water and electrolytes in conscious dogs.
    Primi MP; Bueno L
    Peptides; 1987; 8(4):619-23. PubMed ID: 2888098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin induced apnoea: prevention by central and peripheral administration of the opiate receptor blocking agent naloxone.
    Härfstrand A; Fuxe K; Kalia M; Agnati LF
    Acta Physiol Scand; 1985 Sep; 125(1):91-5. PubMed ID: 2864786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior.
    Rezek M; Havlicek V; Hughes KR; Friesen H
    Pharmacol Biochem Behav; 1976 Jul; 5(1):73-7. PubMed ID: 1033564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors.
    Kamei J; Kawashima N; Kasuya Y
    Brain Res; 1992 Oct; 592(1-2):101-5. PubMed ID: 1450902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
    Suh HH; Fujimoto JM; Tseng LL
    Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues.
    McKeen ES; Feniuk W; Humphrey PP
    Br J Pharmacol; 1994 Oct; 113(2):628-34. PubMed ID: 7834217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adrenal-mediated, naloxone-reversible increase in reaction time in the tail-flick test following intrathecal administration of substance P at the lower thoracic spinal level in the rat.
    Cridland RA; Henry JL
    Neuroscience; 1988 Jul; 26(1):243-51. PubMed ID: 2458544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epileptic properties of leucine- and methionine-enkephalin: comparison with morphine and reversibility by naloxone.
    Frenk H; Urca G; Liebeskind JC
    Brain Res; 1978 May; 147(2):327-37. PubMed ID: 206315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat.
    Guo TZ; Poree L; Golden W; Stein J; Fujinaga M; Maze M
    Anesthesiology; 1996 Oct; 85(4):846-52. PubMed ID: 8873555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opiate-like peptides, morphine, and naloxone in the photosensitive baboon, Papio papio.
    Meldrum BS; Menini C; Stutzmann JM; Naquet R
    Brain Res; 1979 Jul; 170(2):333-48. PubMed ID: 223724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin mydriasis in mice.
    Eshel Y; Sarne Y; Korczyn AD
    Life Sci; 1983 Mar; 32(10):1053-6. PubMed ID: 6131366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.